Amalgamated Bank Amneal Pharmaceuticals, Inc. Transaction History

Amalgamated Bank

$12.2 Billion
Q4 2024

A detailed history of Amalgamated Bank transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 4,144 shares of AMRX stock, worth $36,840. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,144

Previous 4,144 -0.0%

Holding current value

$36,840

Previous $34,000 2.94%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$5.24 - $6.34 $30,454 - $36,848	-5,812 Reduced 58.38%	4,144 $25,000
Q4 2023 Feb 06, 2024	SELL	$3.36 - $6.21 $3,430 - $6,340	-1,021 Reduced 9.3%	9,956 $60,000
Q2 2023 Aug 11, 2023	SELL	$1.33 - $3.1 $4,266 - $9,944	-3,208 Reduced 22.62%	10,977 $34,000
Q1 2023 May 02, 2023	SELL	$1.27 - $2.7 $2,744 - $5,834	-2,161 Reduced 13.22%	14,185 $20,000
Q3 2022 Nov 09, 2022	BUY	$2.02 - $3.62 $537 - $962	266 Added 1.65%	16,346 $33,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $466 - $691	-155 Reduced 0.95%	16,080 $51,000
Q1 2022 Jun 30, 2022	SELL	$3.9 - $4.89 $5,343 - $6,699	-1,370 Reduced 7.78%	16,235 $68,000
Q4 2021 Feb 15, 2022	SELL	$3.95 - $5.85 $750 - $1,111	-190 Reduced 1.07%	17,605 $84,000
Q3 2021 Oct 29, 2021	SELL	$4.31 - $5.64 $4,465 - $5,843	-1,036 Reduced 5.5%	17,795 $95,000
Q2 2021 Aug 16, 2021	BUY	$5.12 - $6.82 $24,683 - $32,879	4,821 Added 34.41%	18,831 $96,000
Q1 2021 May 13, 2021	SELL	$4.74 - $7.38 $6,650 - $10,354	-1,403 Reduced 9.1%	14,010 $94,000
Q4 2020 Feb 12, 2021	BUY	$3.95 - $5.42 $347 - $476	88 Added 0.57%	15,413 $70,000
Q3 2020 Oct 30, 2020	SELL	$3.54 - $5.27 $1,270 - $1,891	-359 Reduced 2.29%	15,325 $59,000
Q2 2020 Aug 10, 2020	SELL	$2.87 - $5.46 $11,055 - $21,031	-3,852 Reduced 19.72%	15,684 $75,000
Q1 2020 May 13, 2020	SELL	$2.46 - $5.35 $1,471 - $3,199	-598 Reduced 2.97%	19,536 $68,000
Q4 2019 Feb 13, 2020	BUY	$2.65 - $5.56 $8,808 - $18,481	3,324 Added 19.77%	20,134 $97,000
Q3 2019 Nov 13, 2019	SELL	$2.29 - $7.1 $309 - $958	-135 Reduced 0.8%	16,810 $49,000
Q2 2019 Aug 14, 2019	BUY	$6.44 - $14.29 $24,214 - $53,730	3,760 Added 28.52%	16,945 $121,000
Q1 2019 May 15, 2019	BUY	$11.87 - $14.84 $4,059 - $5,075	342 Added 2.66%	13,185 $187,000
Q4 2018 Feb 15, 2019	BUY	$13.09 - $21.49 $168,114 - $275,996	12,843 New	12,843 $174,000
Q3 2018 Nov 14, 2018	SELL	$16.4 - $24.27 $218,005 - $322,621	-13,293 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$13.95 - $20.2 $185,437 - $268,518	13,293 New	13,293 $218,000

Others Institutions Holding AMRX

# of Institutions

204

Shares Held

124M

Call Options Held

362K

Put Options Held

141K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.35B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Amneal Pharmaceuticals, Inc. Transaction History